Market Place
Sourcing Support
Inventiva to Present Ph 2 Lanifibranor & Empagliflozin Data at AASLD
15 Nov 2024 //
GLOBENEWSWIRE
Prinston`s Generics Empagliflozin Receives Tentative Approval in US
15 Oct 2024 //
FDA
Lupin receives FDA tentative marketing approval for generic Trijardy XR tablets
09 Jul 2024 //
PHARMABIZ
Lupin Pharm`s Generic Empagliflozin Receives Tentative Approval in US
08 Jul 2024 //
FDA
Eli Lilly reports 67% increase in Q1 2024 net income
01 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Lilly’s growth drivers, Verzenio and Jardiance, suffer setbacks
01 May 2024 //
FIERCE PHARMA
Prinston Pharma`s Generic Empagliflozin Receives Tentative Approval in U.S
11 Apr 2024 //
FDA
EMPACT-MI Ph3 Jardiance® Post-Heart Attack Results
06 Apr 2024 //
PRESS RELEASE
Inventiva to present the results of LEGEND Phase IIa combination trial
13 Mar 2024 //
GLOBENEWSWIRE
??Boehringer`s Jardiance now gets CDSCO nod for chronic kidney disease
14 Feb 2024 //
ECONOMIC TIMES
Boehringer`s aldosterone synthase inhibitor shows promise in CKD trial
04 Nov 2023 //
PRESS RELEASE
Boehringer Ingelheim achieves major milestone in chronic kidney disease
03 Nov 2023 //
BUSINESSWIRE
Boehringer agrees to comply with CMS` price negotiations over Jardiance
27 Sep 2023 //
ENDPTS
US FDA approves Jardiance for the treatment of chronic kidney disease
23 Sep 2023 //
PR NEWSWIRE
US details first 10 drugs subject to Medicare price negotiations
30 Aug 2023 //
REUTERS
Jardiance cleared in EU for CKD, challenging Forxiga
26 Jul 2023 //
PHARMAPHORUM
Jardiance recommended for the treatment of chronic kidney disease in the EU
24 Jun 2023 //
BUSINESSWIRE
FDA grants access to new class of paediatric diabetes medicine
21 Jun 2023 //
PHARMACEUTICAL TECHNOLOGY
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
20 Jun 2023 //
PR NEWSWIRE
Sun`s Generic Empagliflozin, Linagliptin Receives Approval in the U.S.
12 Jun 2023 //
FDA
Boehringer`s profit up as Jardiance gains offset higher costs
30 Mar 2023 //
REUTERS
Heart failure approvals help BI, Lilly`s Jardiance rake in $6.3B
29 Mar 2023 //
FIERCE PHARMA
Enforcement Report - Week of March 29, 2023
29 Mar 2023 //
FDA
The USDMF For Empagliflozin API Submitted -Scaled Up A Lean Process created
27 Mar 2023 //
PRESS RELEASE
Sun`s Generic Empagliflozin Receives Approval in U.S.
10 Mar 2023 //
FDA
NICE fails to recommend Boehringer Ingelheim and Lilly Alliance’s empagliflozin
08 Feb 2023 //
PHARMATIMES
MSN`s Generic Empagliflozin Receives Approval in the U.S.
30 Jan 2023 //
FDA
FDA accepts Lilly-Boehringer Ingelheim’ sNDA for Jardiance
23 Jan 2023 //
PHARMACEUTICAL TECHNOLOGY
US FDA accepts supplemental NDA for Jardiance for chronic kidney disease
20 Jan 2023 //
PR NEWSWIRE
Torrent enters into co-marketing partnership with Boehringer Ingelheim India
15 Dec 2022 //
INDIANPHARMAPOST
Lilly says 4 launches will help drive 2023 revenue to $30B
14 Dec 2022 //
FIERCEPHARMA
PIII trial demonstrated Jardiance show reduction in blood sugar
07 Dec 2022 //
BUSINESSWIRE
Jardiance® improves blood sugar control in type 2 diabetes
07 Dec 2022 //
EUROPEANPHARMACEUTICALREVIEW
Lilly, Boehringer say Jardiance slows kidney disease progression in trial
05 Nov 2022 //
REUTERS
Landmark EMPA-KIDNEY trial showed benefit of Jardiance in kidney disease
04 Nov 2022 //
BUSINESSWIRE
Alkem`s Generic Empagliflozin Receives Approval in the U.S.
28 Sep 2022 //
FDA
Alkem`s Generic Empagliflozin, Linagliptin Receives Approval in the U.S.
09 Aug 2022 //
FDA
Zydus gets final US FDA approval for Empagliflozin tablets
04 Aug 2022 //
EXPRESS PHARMA
Sales of Boehringer`s diabetes, pulmonary drugs jump within $11B+ H1 total
04 Aug 2022 //
ENDPTS
Zydus Pharmaceuticals Generic Empagliflozin Receives Approval in the U.S.
03 Aug 2022 //
FDA
Zydus receives final approval from USFDA for type 2 diabetes tablets
03 Aug 2022 //
ECONOMIC TIMES
Zydus receives final FDA approval for type 2 diabetes drug
11 Jul 2022 //
ET HEALTH
Zydus Pharmaceuticals Generic Empagliflozin Receives Approval in US
07 Jul 2022 //
FDA
Inventiva announces screening of first patient in LEGEND, PIIa combination trial
07 Jul 2022 //
GLOBENEWSWIRE
Jardiance poised for challenge to AZ`s Farxiga in CKD: Spherix
24 Jun 2022 //
FIERCEPHARMA
Jardiance decreased relative risk of hospitalization for heart failure by 50%
05 Jun 2022 //
PRNEWSWIRE
BI gets CDSCO nod for Jardiance to treat for new heart failure indication
19 May 2022 //
ECONOMIC TIMES
Eli Lilly and Boehringer Ingelheim urge women to become their own heart
21 Apr 2022 //
ENDPTS
Jardiance sales reach €3.9B for Boehringer Ingelheim in 2021
06 Apr 2022 //
FIERCEPHARMA
Boehringer`s operating income edges up on Jardiance, animal health
05 Apr 2022 //
REUTERS
Himachal Pradesh high court restrains DRL from selling BI`s Jardiance
01 Apr 2022 //
ECONOMIC TIMES
Jardiance P III EMPA-KIDNEY trial stops early due to clear +ve efficacy in CKD
16 Mar 2022 //
PRNEWSWIRE
Lilly`s Jardiance bags heart failure label expansion in Europe
08 Mar 2022 //
FIERCEPHARMA
Empagliflozin benefits adults hospitalised for acute heart failure, shows study
04 Mar 2022 //
EUROPEANPHARMACEUTICALREVIEW
Jardiance provided clinical benefit in adults stabilized in hospital for AHF
01 Mar 2022 //
PRNEWSWIRE
Lilly and BI`s Jardiance widens scope of heart failure approval
25 Feb 2022 //
SEEKINGALPHA
NICE approves new treatment for chronic heart failure
07 Feb 2022 //
PHARMAFILE
CHMP issues positive opinion to expand Jardiance indication in heart failure
28 Jan 2022 //
BUSINESSWIRE
Lilly is gearing up for the launch of two crucial new meds
21 Dec 2021 //
FIERCEPHARMA
